Miss Meline Almasi is a Montrose, California based nurse practitioner. Active license number of Miss Meline Almasi is 95002999 for Family in California. Her current practice location is 2037 Verdugo Blvd, Montrose. Patients can reach her at 866-389-2727. Miss Meline Almasi is NP and her NPI number (Unique professional ID assigned by NPPES) is 1265809800. Miss Meline Almasi has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Miss Meline Almasi speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1265809800
NPI Enumeration Date:
31 Aug, 2015
NPI Last Update On:
14 May, 2016
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Miss Meline Almasi are as mentioned below.
License Number
Specialization
State
Status
95002999
Family
California
Primary
768694
Registered Nurse
California
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Miss Meline Almasi 1322 Linden Ave, Glendale, California
Zip:
91201-1118
Patients can reach Miss Meline Almasi at 2037 Verdugo Blvd, Montrose, California or can call to book an appointment on 866-389-2727.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.